English
简体中文
Total: £ 56.28
Published Date: 2024-03-29 | Pages: 89 | Tables: 170 | Medical Care
Preimplantation genetic screening (PGS) determines the chromosomal status of an embryo by screening all 23 chromosome pairs prior to transfer in an IVF cycle.
The global Preimplantation Genetic Screening (PGS) Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Preimplantation Genetic Screening (PGS) Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preimplantation Genetic Screening (PGS) Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Preimplantation Genetic Screening (PGS) Technology in Maternity Centers & Fertility Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Preimplantation Genetic Screening (PGS) Technology include Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Coopersurgical, Natera, Takara Bio, Oxford Gene Technology and INVICTA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetic Screening (PGS) Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetic Screening (PGS) Technology.
Report Scope
The Preimplantation Genetic Screening (PGS) Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preimplantation Genetic Screening (PGS) Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preimplantation Genetic Screening (PGS) Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
Agilent Technologies
PerkinElmer
Coopersurgical
Natera
Takara Bio
Oxford Gene Technology
INVICTA
Genea
Progenesis
Igenomix
Reproductive Health and Wellness Center
Segment by Type
Next-generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-nucleotide Polymorphism
Segment by Application
Maternity Centers & Fertility Clinics
Hospitals
Research Laboratories & Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preimplantation Genetic Screening (PGS) Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Next-generation Sequencing
1.2.3 Polymerase Chain Reaction
1.2.4 Fluorescence in Situ Hybridization
1.2.5 Comparative Genomic Hybridization
1.2.6 Single-nucleotide Polymorphism
1.3 Market by Application
1.3.1 Global Preimplantation Genetic Screening (PGS) Technology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Maternity Centers & Fertility Clinics
1.3.3 Hospitals
1.3.4 Research Laboratories & Academic Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Perspective (2019-2030)
2.2 Preimplantation Genetic Screening (PGS) Technology Growth Trends by Region
2.2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Region (2019-2024)
2.2.3 Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Region (2025-2030)
2.3 Preimplantation Genetic Screening (PGS) Technology Market Dynamics
2.3.1 Preimplantation Genetic Screening (PGS) Technology Industry Trends
2.3.2 Preimplantation Genetic Screening (PGS) Technology Market Drivers
2.3.3 Preimplantation Genetic Screening (PGS) Technology Market Challenges
2.3.4 Preimplantation Genetic Screening (PGS) Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetic Screening (PGS) Technology Players by Revenue
3.1.1 Global Top Preimplantation Genetic Screening (PGS) Technology Players by Revenue (2019-2024)
3.1.2 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Players (2019-2024)
3.2 Global Preimplantation Genetic Screening (PGS) Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetic Screening (PGS) Technology Revenue
3.4 Global Preimplantation Genetic Screening (PGS) Technology Market Concentration Ratio
3.4.1 Global Preimplantation Genetic Screening (PGS) Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Screening (PGS) Technology Revenue in 2023
3.5 Preimplantation Genetic Screening (PGS) Technology Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetic Screening (PGS) Technology Product Solution and Service
3.7 Date of Enter into Preimplantation Genetic Screening (PGS) Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetic Screening (PGS) Technology Breakdown Data by Type
4.1 Global Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Type (2019-2024)
4.2 Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Type (2025-2030)
5 Preimplantation Genetic Screening (PGS) Technology Breakdown Data by Application
5.1 Global Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Application (2019-2024)
5.2 Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size (2019-2030)
6.2 North America Preimplantation Genetic Screening (PGS) Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2019-2024)
6.4 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size (2019-2030)
7.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2019-2024)
7.4 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size (2019-2030)
8.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2019-2024)
8.4 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size (2019-2030)
9.2 Latin America Preimplantation Genetic Screening (PGS) Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2019-2024)
9.4 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size (2019-2030)
10.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2019-2024)
10.4 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Preimplantation Genetic Screening (PGS) Technology Introduction
11.1.4 Illumina Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Introduction
11.2.4 Thermo Fisher Scientific Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Introduction
11.3.4 Agilent Technologies Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Detail
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Introduction
11.4.4 PerkinElmer Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.4.5 PerkinElmer Recent Development
11.5 Coopersurgical
11.5.1 Coopersurgical Company Detail
11.5.2 Coopersurgical Business Overview
11.5.3 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Introduction
11.5.4 Coopersurgical Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.5.5 Coopersurgical Recent Development
11.6 Natera
11.6.1 Natera Company Detail
11.6.2 Natera Business Overview
11.6.3 Natera Preimplantation Genetic Screening (PGS) Technology Introduction
11.6.4 Natera Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.6.5 Natera Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Detail
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Preimplantation Genetic Screening (PGS) Technology Introduction
11.7.4 Takara Bio Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.7.5 Takara Bio Recent Development
11.8 Oxford Gene Technology
11.8.1 Oxford Gene Technology Company Detail
11.8.2 Oxford Gene Technology Business Overview
11.8.3 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Introduction
11.8.4 Oxford Gene Technology Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.8.5 Oxford Gene Technology Recent Development
11.9 INVICTA
11.9.1 INVICTA Company Detail
11.9.2 INVICTA Business Overview
11.9.3 INVICTA Preimplantation Genetic Screening (PGS) Technology Introduction
11.9.4 INVICTA Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.9.5 INVICTA Recent Development
11.10 Genea
11.10.1 Genea Company Detail
11.10.2 Genea Business Overview
11.10.3 Genea Preimplantation Genetic Screening (PGS) Technology Introduction
11.10.4 Genea Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.10.5 Genea Recent Development
11.11 Progenesis
11.11.1 Progenesis Company Detail
11.11.2 Progenesis Business Overview
11.11.3 Progenesis Preimplantation Genetic Screening (PGS) Technology Introduction
11.11.4 Progenesis Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.11.5 Progenesis Recent Development
11.12 Igenomix
11.12.1 Igenomix Company Detail
11.12.2 Igenomix Business Overview
11.12.3 Igenomix Preimplantation Genetic Screening (PGS) Technology Introduction
11.12.4 Igenomix Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.12.5 Igenomix Recent Development
11.13 Reproductive Health and Wellness Center
11.13.1 Reproductive Health and Wellness Center Company Detail
11.13.2 Reproductive Health and Wellness Center Business Overview
11.13.3 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Introduction
11.13.4 Reproductive Health and Wellness Center Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
11.13.5 Reproductive Health and Wellness Center Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Next-generation Sequencing
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Fluorescence in Situ Hybridization
Table 5. Key Players of Comparative Genomic Hybridization
Table 6. Key Players of Single-nucleotide Polymorphism
Table 7. Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Region (2019-2024)
Table 11. Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Region (2025-2030)
Table 13. Preimplantation Genetic Screening (PGS) Technology Market Trends
Table 14. Preimplantation Genetic Screening (PGS) Technology Market Drivers
Table 15. Preimplantation Genetic Screening (PGS) Technology Market Challenges
Table 16. Preimplantation Genetic Screening (PGS) Technology Market Restraints
Table 17. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Players (2019-2024)
Table 19. Global Top Preimplantation Genetic Screening (PGS) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Screening (PGS) Technology as of 2023)
Table 20. Ranking of Global Top Preimplantation Genetic Screening (PGS) Technology Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Preimplantation Genetic Screening (PGS) Technology Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Preimplantation Genetic Screening (PGS) Technology Product Solution and Service
Table 24. Date of Enter into Preimplantation Genetic Screening (PGS) Technology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type (2019-2024)
Table 28. Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type (2025-2030)
Table 30. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application (2019-2024)
Table 32. Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application (2025-2030)
Table 34. North America Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2025-2030) & (US$ Million)
Table 49. Illumina Company Detail
Table 50. Illumina Business Overview
Table 51. Illumina Preimplantation Genetic Screening (PGS) Technology Product
Table 52. Illumina Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 53. Illumina Recent Development
Table 54. Thermo Fisher Scientific Company Detail
Table 55. Thermo Fisher Scientific Business Overview
Table 56. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Product
Table 57. Thermo Fisher Scientific Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 58. Thermo Fisher Scientific Recent Development
Table 59. Agilent Technologies Company Detail
Table 60. Agilent Technologies Business Overview
Table 61. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Product
Table 62. Agilent Technologies Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 63. Agilent Technologies Recent Development
Table 64. PerkinElmer Company Detail
Table 65. PerkinElmer Business Overview
Table 66. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Product
Table 67. PerkinElmer Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 68. PerkinElmer Recent Development
Table 69. Coopersurgical Company Detail
Table 70. Coopersurgical Business Overview
Table 71. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Product
Table 72. Coopersurgical Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 73. Coopersurgical Recent Development
Table 74. Natera Company Detail
Table 75. Natera Business Overview
Table 76. Natera Preimplantation Genetic Screening (PGS) Technology Product
Table 77. Natera Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 78. Natera Recent Development
Table 79. Takara Bio Company Detail
Table 80. Takara Bio Business Overview
Table 81. Takara Bio Preimplantation Genetic Screening (PGS) Technology Product
Table 82. Takara Bio Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 83. Takara Bio Recent Development
Table 84. Oxford Gene Technology Company Detail
Table 85. Oxford Gene Technology Business Overview
Table 86. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Product
Table 87. Oxford Gene Technology Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 88. Oxford Gene Technology Recent Development
Table 89. INVICTA Company Detail
Table 90. INVICTA Business Overview
Table 91. INVICTA Preimplantation Genetic Screening (PGS) Technology Product
Table 92. INVICTA Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 93. INVICTA Recent Development
Table 94. Genea Company Detail
Table 95. Genea Business Overview
Table 96. Genea Preimplantation Genetic Screening (PGS) Technology Product
Table 97. Genea Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 98. Genea Recent Development
Table 99. Progenesis Company Detail
Table 100. Progenesis Business Overview
Table 101. Progenesis Preimplantation Genetic Screening (PGS) Technology Product
Table 102. Progenesis Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 103. Progenesis Recent Development
Table 104. Igenomix Company Detail
Table 105. Igenomix Business Overview
Table 106. Igenomix Preimplantation Genetic Screening (PGS) Technology Product
Table 107. Igenomix Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 108. Igenomix Recent Development
Table 109. Reproductive Health and Wellness Center Company Detail
Table 110. Reproductive Health and Wellness Center Business Overview
Table 111. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Product
Table 112. Reproductive Health and Wellness Center Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024) & (US$ Million)
Table 113. Reproductive Health and Wellness Center Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetic Screening (PGS) Technology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Type: 2023 VS 2030
Figure 3. Next-generation Sequencing Features
Figure 4. Polymerase Chain Reaction Features
Figure 5. Fluorescence in Situ Hybridization Features
Figure 6. Comparative Genomic Hybridization Features
Figure 7. Single-nucleotide Polymorphism Features
Figure 8. Global Preimplantation Genetic Screening (PGS) Technology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Application: 2023 VS 2030
Figure 10. Maternity Centers & Fertility Clinics Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Research Laboratories & Academic Institutes Case Studies
Figure 13. Others Case Studies
Figure 14. Preimplantation Genetic Screening (PGS) Technology Report Years Considered
Figure 15. Global Preimplantation Genetic Screening (PGS) Technology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Preimplantation Genetic Screening (PGS) Technology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Region: 2023 VS 2030
Figure 18. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Players in 2023
Figure 19. Global Top Preimplantation Genetic Screening (PGS) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Screening (PGS) Technology as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Preimplantation Genetic Screening (PGS) Technology Revenue in 2023
Figure 21. North America Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2019-2030)
Figure 23. United States Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2019-2030)
Figure 27. Germany Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Share by Region (2019-2030)
Figure 35. China Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2019-2030)
Figure 43. Mexico Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2019-2030)
Figure 47. Turkey Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Illumina Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 51. Agilent Technologies Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 52. PerkinElmer Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 53. Coopersurgical Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 54. Natera Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 55. Takara Bio Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 56. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 57. INVICTA Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 58. Genea Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 59. Progenesis Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 60. Igenomix Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 61. Reproductive Health and Wellness Center Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
